Literature DB >> 23168774

Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix.

Alan G Waxman, David Chelmow, Teresa M Darragh, Herschel Lawson, Anna-Barbara Moscicki.   

Abstract

In March 2012, the College of American Pathologists and American Society for Colposcopy and Cervical Pathology, in collaboration with 35 stakeholder organizations, convened a consensus conference called the Lower Anogenital Squamous Terminology (LAST) Project. The recommendations of this project include using a uniform, two-tiered terminology to describe the histology of human papillomavirus-associated squamous disease across all anogenital tract tissues: vulva, vagina, cervix, penis, perianus, and anus. The recommended terminology is "low-grade" or "high-grade squamous intraepithelial lesion (SIL)." This terminology is familiar to clinicians, because it parallels the terminology of the Bethesda System cytologic reports. Biopsy results using SIL terminology may be further qualified using "intraepithelial neoplasia" (IN) terminology in parentheses. Laboratory p16 tissue immunostaining is recommended to better classify histopathology lesions that morphologically would earlier have been diagnosed as IN 2. p16 is also recommended for differentiating between high-grade squamous intraepithelial lesions and benign mimics. The LAST Project recommendations potentially affect the application of current guidelines for managing cervical squamous intraepithelial lesions. The authors offer interim guidance for managing cervical lesions diagnosed using this new terminology with special attention paid to managing young women with cervical high-grade squamous intraepithelial lesions on biopsy. Clinicians should be aware of the LAST Project recommendations, which include important changes from prior terminology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23168774      PMCID: PMC4054813          DOI: 10.1097/aog.0b013e31827001d5

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  33 in total

1.  From human papillomavirus to cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen
Journal:  Obstet Gynecol       Date:  2010-07       Impact factor: 7.661

Review 2.  The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology.

Authors:  Teresa M Darragh; Terence J Colgan; J Thomas Cox; Debra S Heller; Michael R Henry; Ronald D Luff; Timothy McCalmont; Ritu Nayar; Joel M Palefsky; Mark H Stoler; Edward J Wilkinson; Richard J Zaino; David C Wilbur
Journal:  J Low Genit Tract Dis       Date:  2012-07       Impact factor: 1.925

3.  Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia.

Authors:  Christine Bergeron; Jaume Ordi; Dietmar Schmidt; Marcus J Trunk; Thomas Keller; Ruediger Ridder
Journal:  Am J Clin Pathol       Date:  2010-03       Impact factor: 2.493

4.  Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.

Authors:  Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Allan Hildesheim; Concepción Bratti; Mark E Sherman; Diane Solomon; Diego Guillén; Mario Alfaro; Jorge Morales; Martha Hutchinson; Hormuzd Katki; Li Cheung; Sholom Wacholder; Robert D Burk
Journal:  J Natl Cancer Inst       Date:  2010-02-15       Impact factor: 13.506

5.  2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.

Authors:  Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon
Journal:  J Low Genit Tract Dis       Date:  2007-10       Impact factor: 1.925

6.  CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples.

Authors:  Joseph D Carreon; Mark E Sherman; Diego Guillén; Diane Solomon; Rolando Herrero; Jose Jerónimo; Sholom Wacholder; Ana Cecilia Rodríguez; Jorge Morales; Martha Hutchinson; Robert D Burk; Mark Schiffman
Journal:  Int J Gynecol Pathol       Date:  2007-10       Impact factor: 2.762

7.  Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.

Authors:  Margaret R E McCredie; Katrina J Sharples; Charlotte Paul; Judith Baranyai; Gabriele Medley; Ronald W Jones; David C G Skegg
Journal:  Lancet Oncol       Date:  2008-04-11       Impact factor: 41.316

8.  Value of p16(INK4a) as a marker of progression/regression in cervical intraepithelial neoplasia grade 1.

Authors:  Marta del Pino; Sònia Garcia; Victòria Fusté; Immaculada Alonso; Pere Fusté; Aureli Torné; Jaume Ordi
Journal:  Am J Obstet Gynecol       Date:  2009-08-15       Impact factor: 8.661

9.  Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomes.

Authors:  Kathleen Moore; Amanda Cofer; Leslie Elliot; Grainger Lanneau; Joan Walker; Michael A Gold
Journal:  Am J Obstet Gynecol       Date:  2007-08       Impact factor: 8.661

Review 10.  Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis.

Authors:  M Arbyn; M Kyrgiou; C Simoens; A O Raifu; G Koliopoulos; P Martin-Hirsch; W Prendiville; E Paraskevaidis
Journal:  BMJ       Date:  2008-09-18
View more
  35 in total

1.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.

Authors:  Olca Basturk; Seung-Mo Hong; Laura D Wood; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Lodewijk A A Brosens; Noriyoshi Fukushima; Michael Goggins; Ralph H Hruban; Yo Kato; David S Klimstra; Günter Klöppel; Alyssa Krasinskas; Daniel S Longnecker; Hanno Matthaei; G Johan A Offerhaus; Michio Shimizu; Kyoichi Takaori; Benoit Terris; Shinichi Yachida; Irene Esposito; Toru Furukawa
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

2.  From Papanicolaou to papillomaviruses: evolving challenges in cervical cancer screening in the era of human papillomavirus vaccination.

Authors:  Mahboobeh Safaeian; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2013-10-04       Impact factor: 13.506

Review 3.  [Nomenclature of squamous cell precursor lesions of the lower female genital tract : Current aspects].

Authors:  L-C Horn; C E Brambs; R Handzel; G Mehlhorn; D Schmidt; K Schierle
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

4.  Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia.

Authors:  N Ari Wijetunga; Thomas J Belbin; Robert D Burk; Kathleen Whitney; Maria Abadi; John M Greally; Mark H Einstein; Nicolas F Schlecht
Journal:  Gynecol Oncol       Date:  2016-07-09       Impact factor: 5.482

5.  Risk of human papillomavirus infection in women with rheumatic disease: cervical cancer screening and prevention.

Authors:  Seoyoung C Kim; Sarah Feldman; Anna-Barbara Moscicki
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

6.  Evaluating the Use of LAST 2-Tiered Nomenclature and Its Impact on Reporting Cervical Lesions in a Population-Based Cancer Registry.

Authors:  Mei-Chin Hsieh; Elizabeth Van Dyne; Christina Lefante; Jean A Shapiro; Paran Pordell; Mary Anne Lynch; Natalie Gomez; Brent Mumphrey; Lauren Maniscalco; Rachna Jetly-Shridhar; Mona Saraiya; Xiao-Cheng Wu
Journal:  J Registry Manag       Date:  2019

7.  Quantitative DNA methylation analysis of paired box gene 1 and LIM homeobox transcription factor 1 α genes in cervical cancer.

Authors:  Ling Xu; Jun Xu; Zheng Hu; Baohua Yang; Lifeng Wang; Xiao Lin; Ziyin Xia; Zhiling Zhang; Yunheng Zhu
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

8.  B7 homolog 6 promotes the progression of cervical cancer.

Authors:  Ruimeng Guo; Guoyan Liu; Changying Li; Xuejing Liu; Yanying Xu; Weina Yang; Fang Wang
Journal:  Exp Ther Med       Date:  2021-05-18       Impact factor: 2.447

9.  The Appropriate of Cone Depth in Loop Electrical Excision Procedure (LEEP) for Negative Pathological Margin from High Grade Precancerous Lesion of Cervix, Retrospective Study.

Authors:  Noppames Srijarusith; Nopporn Rodpenpear
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

10.  Use of extended HR-HPV Genotyping in improving the Triage Strategy of 2019 ASCCP recommendations in Women with positive HR-HPV diagnosis and Simultaneous LSIL Cytology Results.

Authors:  Huifeng Xue; Hangjing Gao; Jinwen Zheng; Yaojia Chen; Jiancui Chen; Diling Pan; Binhua Dong; Pengming Sun
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.